Characterisation of a Novel A-Superfamily Conotoxin.

NMR spectroscopy conopeptide disulfide framework

Journal

Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304

Informations de publication

Date de publication:
20 May 2020
Historique:
received: 03 05 2020
revised: 15 05 2020
accepted: 18 05 2020
entrez: 24 5 2020
pubmed: 24 5 2020
medline: 24 5 2020
Statut: epublish

Résumé

Conopeptides belonging to the A-superfamily from the venomous molluscs,

Identifiants

pubmed: 32443665
pii: biomedicines8050128
doi: 10.3390/biomedicines8050128
pmc: PMC7277881
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Australian Research Council
ID : LE160100218
Organisme : Australian Research Council
ID : FF110100226

Références

Biochem Pharmacol. 2015 Mar 15;94(2):155-63
pubmed: 25646788
Pharmacol Ther. 2013 Jan;137(1):22-54
pubmed: 22925690
Mol Pharmacol. 2012 Oct;82(4):711-8
pubmed: 22802270
Toxicon. 2012 Mar 15;59(4):524-8
pubmed: 21839105
Angew Chem Int Ed Engl. 2010 Sep 3;49(37):6545-8
pubmed: 20533477
Expert Opin Ther Pat. 2015;25(10):1159-73
pubmed: 26065897
Eur J Pharmacol. 2019 Dec 15;865:172674
pubmed: 31634461
Neurosci Lett. 2018 Jul 13;679:24-34
pubmed: 29199094
Biochem Pharmacol. 2012 Jun 1;83(11):1562-71
pubmed: 22410003
Bioinformatics. 2008 Feb 1;24(3):445-6
pubmed: 18065428
J Proteomics. 2019 Jan 6;190:12-20
pubmed: 29777871
Curr Pharm Des. 2016;22(5):582-9
pubmed: 26601961
Br J Pharmacol. 2018 Jun;175(12):2384-2398
pubmed: 29194563
Nucleic Acids Res. 2012 Jan;40(Database issue):D325-30
pubmed: 22058133
Magn Reson Chem. 2006 Jul;44 Spec No:S41-50
pubmed: 16826542
Mar Drugs. 2019 Sep 16;17(9):
pubmed: 31527432
Toxins (Basel). 2019 Feb 20;11(2):
pubmed: 30791616
J Biomol NMR. 2016 Oct;66(2):111-124
pubmed: 27663422
Lancet. 2010 May 1;375(9725):1569-77
pubmed: 20413151
Sci Rep. 2015 Aug 20;5:13264
pubmed: 26290113
Proteomics. 2015 Dec;15(23-24):4030-40
pubmed: 26506909
Biochem Pharmacol. 2010 Mar 15;79(6):908-20
pubmed: 19883631
J Mol Graph. 1996 Feb;14(1):51-5, 29-32
pubmed: 8744573
Sci Rep. 2018 Sep 7;8(1):13397
pubmed: 30194442
Int J Mol Sci. 2018 Mar 09;19(3):
pubmed: 29522462
J Biomol NMR. 2013 Jul;56(3):227-41
pubmed: 23728592
Biochemistry. 1998 Nov 10;37(45):15621-30
pubmed: 9843366
Acta Pharmacol Sin. 2009 Jun;30(6):771-83
pubmed: 19448650
J Biol Chem. 2006 Aug 11;281(32):23254-63
pubmed: 16754662
J Biomol NMR. 1995 Jan;5(1):67-81
pubmed: 7881273
Epilepsy Res. 2004 Mar;59(1):13-24
pubmed: 15135163
Chem Rev. 2019 Nov 13;119(21):11510-11549
pubmed: 31633928
Mar Drugs. 2014 Dec 17;12(12):6058-101
pubmed: 25522317
ACS Chem Biol. 2018 Jun 15;13(6):1577-1587
pubmed: 29746088
Front Pharmacol. 2019 May 31;10:577
pubmed: 31214027
Arch Biochem Biophys. 2017 Aug 15;628:24-32
pubmed: 28263718

Auteurs

David T Wilson (DT)

Centre for Molecular Therapeutics, Australian Institute of Tropical Health and Medicine, James Cook University, Smithfield, QLD 4878, Australia.

Paramjit S Bansal (PS)

Centre for Molecular Therapeutics, Australian Institute of Tropical Health and Medicine, James Cook University, Smithfield, QLD 4878, Australia.

David A Carter (DA)

Centre for Pain Research, Institute for Molecular Bioscience, The University of Queensland, St Lucia, QLD 4072, Australia.

Irina Vetter (I)

Centre for Pain Research, Institute for Molecular Bioscience, The University of Queensland, St Lucia, QLD 4072, Australia.
School of Pharmacy, The University of Queensland, Woolloongabba, QLD 4102, Australia.

Annette Nicke (A)

Walther Straub Institute of Pharmacology and Toxicology, Faculty of Medicine, LMU Munich, Nußbaumstraße 26, 80336 Munich, Germany.

Sébastien Dutertre (S)

Institut des Biomolécules Max Mousseron, UMR 5247, Université de Montpellier, CNRS, 34095 Montpellier, France.

Norelle L Daly (NL)

Centre for Molecular Therapeutics, Australian Institute of Tropical Health and Medicine, James Cook University, Smithfield, QLD 4878, Australia.

Classifications MeSH